Table A1.15Population EVPI

WTP threshold values(£)Population EVPI(£)
3 Year5 Year10 Year
5,0005,0467,32012,365
10,000235,188341,189576,372
15,0001,199,7171,740,4362,940,127
20,0002,866,2524,158,0867,024,275
25,0003,623,2765,256,3038,879,499
30,0004,867,6947,061,58611,929,172
35,0006,433,4529,333,03815,766,347
40,0008,217,75611,921,53620,139,110
50,00012,033,19317,456,60829,489,535

From: Appendix 1, What is the expected value of perfect information in reducing uncertainty surrounding the cost-effectiveness of systemic treatment in patients with confirmed carcinoma of unknown primary and no clinical features fitting a recognised syndrome?

Cover of Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin
Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin.
NICE Clinical Guidelines, No. 104.
National Collaborating Centre for Cancer (UK).
Copyright © 2010, National Collaborating Centre for Cancer.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licenses issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.